Oct4/miR-1246 in CD133+ HCC is correlated with a poor diagnosis which promotes cancer stemness through activation of the Wnt/β-catenin pathway through miR-1246 targeting to degradation of β-catenin complexes suppressing AXIN2 and GSK3β expression [183]. Here, PROM1 is linked to cancer.